Experimental autoimmune encephalomyelitis-induced upregulation of tumor necrosis factor-alpha in the dorsal root ganglia

Multiple Sclerosis

Volumn 15, Issue 10, 2009, Pages 1135-1145

  Melanson, M ^a   Miao, P ^a   Eisenstat, D ^a,b   Gong, Y ^a   Gu, X ^a   Au, K ^a   Zhu, W ^a   Begum, F ^a   Frost, E E ^a   Namaka, M ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

DRG; EAE; Multiple sclerosis; Neuropathic pain; Tumor necrosis factor alpha

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD; SPINAL GANGLION; TH1 CELL; UPREGULATION;

ANIMALS; DISABILITY EVALUATION; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GANGLIA, SPINAL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MULTIPLE SCLEROSIS; PAIN; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; USER-COMPUTER INTERFACE;

EID: 72449136385     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509106856     Document Type: Article

References (70)

1. 1. Ransohoff RM. Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines. J Neuroimmunol 1999; 98: 57-68. (Pubitemid 29295408)
2. 2. Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 2006; 52: 61-76. (Pubitemid 44466355)
3. 1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal. Trends Immunol 2004; 25: 132-137.
4. Zeis T, Graumann U, Reynolds R, Schaeren-Wiemers N. Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 2008; 131(Pt 1): 288-303.
5. 5. Dhib-Jalbut S, Jiang H, Williams GJ. The effect of interferon beta-lb on lymphocyte-endothelial cell adhesion. J Neuroimmunol 1996; 71: 215-222. (Pubitemid 26413275)
6. Merrill JE. Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. J lmmunother (1991) 1992; 12: 167-170.
7. Kornek B, Lassmann H. Neuropathology of multiple sclerosis-new concepts. Brain Res Bull 2003; 61: 321-326.
8. 8. Nakazawa T, Nakazawa C, Matsubara A, et al. Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci 2006; 26: 12633-12641. (Pubitemid 44904557)
9. Pollmann W, Feneberg W. Current management of pain associated with multiple sclerosis. CNS Drugs 2008; 22: 291-324.
10. 10. Nelson DA. Dorsal root ganglia may be reservoirs of viral infection in multiple sclerosis. Med Hypotheses 1993; 40: 278-283. (Pubitemid 23175302)
11. Chatel M, Lanteri-Minet M, Lebrun-Frenay C. Pain in multiple sclerosis. Rev Neurol (Paris) 2001; 157(8-9 Pt 2): 1072-1078.
12. 12. Portenoy RK, Yang K, Thorton D. Chronic intractable pain: an atypical presentation of multiple sclerosis. J Neurol 1988; 235: 226-228. (Pubitemid 18096691)
13. 13. Ende DM, Osborne TL, Hanley MA, Jensen MP, Kraft GH. The scope and nature of pain in persons with multiple sclerosis. Mult Scler 2006; 12: 629-638. (Pubitemid 46940637)
14. Zeid NA, Bhatti MT. Acute inflammatory demyelinating optic neuritis: evidence-based visual and neurological considerations. Neurologist 2008; 14: 207-223.
15. 15. Jakeman LB, Guan Z, Wei P, et al. Traumatic spinal cord injury produced by controlled contusion in mouse. J Neurotrauma 2000; 17: 299-319. (Pubitemid 30205483)
16. 16. Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, Feldman EL. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurohiol Dis 1999; 6: 347-363. (Pubitemid 29496214)
17. 17. Srinivasan S, Stevens M, Wiley JW. Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 2000; 49: 1932-1938. (Pubitemid 30812928)
18. Campana WM, Myers RR. Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury. Eur J Neurosci 2003; 18: 1497-1506.
19. 19. Schenker M, Kraftsik R, Glauser L, Kuntzer T, Bogousslavsky J, Barakat-Walter I, Thyroid hormone reduces the loss of axotomized sensory neurons in dorsal root ganglia after sciatic nerve transection in adult rat. Exp Neurol 2003; 184: 225-236. (Pubitemid 37444033)
20. Namaka M, Gramlich CR, Ruhlen D, Melanson M, Sutton I, Major J. A treatment algorithm for neuropathic pain. Clin Ther 2004; 26: 951-979.
21. 21. Sommer C, Schmidt C, George A. Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1. Exp Neurol 1998; 151: 138-142. (Pubitemid 28223862)
22. Hermann GE, Rogers RC, Bresnahan JC, Beattie MS. Tumor necrosis factor-alpha induces cFOS and strongly potentiates glutamate-mediated cell death in the rat spinal cord. Neurobiol Dis 2001; 8: 590-599.
23. Racz I, Nadal X, Alferink J, et al. Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain. J Neurosci 2008; 28: 12125-12135.
24. 24. Ueda H, Levine JM, Miller RH, Trapp BD. Rat optic nerve oligodendrocytes develop in the absence of viable retinal ganglion cell axons. J Cell Biol 1999; 146: 1365-1374. (Pubitemid 29477701)
25. 25. Miao P, Madec K, Gong Y, et al. Axotomy-induced upregulation of tumor necrosis factor-alpha in the dorsal root ganglia. Neurol Res 2008; 30: 623-631. (Pubitemid 352032561)
26. 26. Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol 1997; 121: 417-424. (Pubitemid 27226293)
27. Cawthorn WP, Sethi JK. TNF-alpha and adipocyte biology. FEBS Lett 2008; 582: 117-131.
28. Chadwick W, Magnus T, Martin B, Keselman A, Mattson MP, Maudsley S. Targeting TNF-alpha receptors for neurotherapeutics. Trends Neurosci 2008; 31: 504-511.
29. Robertson CP, Gibbs SM, Roelink H. cGMP enhances the sonic hedgehog response in neural plate cells. Dev Biol 2001; 238: 157-167.
30. Petryniak MA, Potter GB, Rowitch DH, Rubenstein JL. Dlxl and Dlx2 control neuronal versus oligodendroglial cell fate acquisition in the developing forebrain. Neuron 2007; 55: 417-433.
31. Swanborg RH. Experimental autoimmune encephalomyelitis in the rat: lessons in T-cell immunology and autoreactivity. Immunol Rev 2001; 184: 129-135.
32. Mannie M, Swanborg RH, Stepaniak JA. Experimental Autoimmune Encephalomyelitis in the rat. Curr Protoc Immunol 2009; April (Chapter 15): Unit 15.2.
33. 33. Gold R, Hartung HP, Toyka KV. Animal models for autoimmune demyelinating disorders of the nervous system. MoI Med Today 2000; 6: 88-91. (Pubitemid 30070671)
34. 34. Zweifel LS, Kuruvilla R, Ginty DD. Functions and mechanisms of retrograde neurotrophin signalling. Nat Rev Neurosci 2005; 6: 615-625. (Pubitemid 41059336)
35. Yip HK, Johnson EM Jr. Comparative dynamics of retrograde transport of nerve growth factor and horseradish peroxidase in rat lumbar dorsal root ganglia. J Neurocytol 1986; 15: 789-798.
36. 36. Richardson PM, Riopelle RJ. Uptake of nerve growth factor along peripheral and spinal axons of primary sensory neurons. J Neurosci 1984; 4: 1683-1689. (Pubitemid 14055525)
37. 37. Qiao LY, Gulick MA, Bowers J, Kuemmerle JF, Grider JR. Differential changes in brain-derived neurotrophic factor and extracellular signal-regulated kinase in rat primary afferent pathways with colitis. Neurogastroenterol Motil 2008; 20: 928-938. (Pubitemid 352019712)
38. 38. Wang TH, Meng QS, Qi JG, Zhang WM, Chen J, Wu LF. NT-3 expression in spared DRG and the associated spinal laminae as well as its anterograde transport in sensory neurons following removal of adjacent DRG in cats. Neurochem Res 2008; 33: 1-7. (Pubitemid 350242782)
39. Nelson DA. Sensory symptoms of multiple sclerosis may be clues to causation: review and a hypothesis. Del Med J 1992; 64: 205-213.
40. Takahashi N, Kikuchi S, Shubayev VI, Campana WM, Myers RR. TNF-alpha and phosphorylation of ERK in DRG and spinal cord: insights into mechanisms of sciatica. Spine 2006; 31: 523-529.
41. 41. Li Y, Ji A, Weihe E, Schafer MK. Cell-specific expression and lipopolysaccharide-induced regulation of tumor necrosis factor alpha (TNFalpha) and TNF receptors in rat dorsal root ganglion. J Neurosci 2004; 24: 9623-9631. (Pubitemid 39441516)
42. 42. Tsujino H, Kondo E, Fukuoka T, et al. Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: a novel neuronal marker of nerve injury. MoI Cell Neurosci 2000; 15: 170-182. (Pubitemid 30109120)
43. 43. Zelenka M, Schafers M, Sommer C Intraneural injection of interleukin-l beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain. Pain 2005; 116: 257-263. (Pubitemid 40957129)
44. 44. Ohtori S, Takahashi K, Moriya H, Myers RR. TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord. Spine 2004; 29: 1082-1088. (Pubitemid 38649821)
45. 45. Ding M, Hart RP, Jonakait GM. Tumor necrosis factoralpha induces substance P in sympathetic ganglia through sequential induction of interleukin-1 and leukemia inhibitory factor. J Neurobiol 1995; 28: 445-454. (Pubitemid 3002491)
46. 46. Frisen J, Verge VM, Fried K, et al. Characterization of glial trkB receptors: differential response to injury in the central and peripheral nervous systems. Proc Natl Acad Sci U S A 1993; 90: 4971-4975. (Pubitemid 23182957)
47. 47. Myers RR, Sekiguchi Y, Kikuchi S, et al. Inhibition of p38 MAP kinase activity enhances axonal regeneration. Exp Neurol 2003; 184: 606-614. (Pubitemid 38182791)
48. 48. Chang YS, Wang L, Suh YA, et al. Mechanisms underlying lack of insulin-like growth factor-binding protein-3 expression in non-small-cell lung cancer. Oncogene 2004; 23: 6569-6580. (Pubitemid 39265520)
49. Xu JT, Xin WJ, Zang Y, Wu CY, Liu XG. The role of tumor necrosis factor-alpha in the neuropathic pain induced by Lumbar 5 ventral root transection in rat. Pain 2006; 123: 306-321.
50. Ji RR, Strichartz G. Cell signaling and the genesis of neuropathic pain. Sci STKE 2004 2004; reEl.4.
51. Czeschik JC, Hagenacker T, Schafers M, Busselberg D. TNF-alpha differentially modulates ion channels of nociceptive neurons. Neurosci Lett 2008; 434: 293-298.
52. Sacerdote P, Franchi S, Trovato AE, Valsecchi AE, Panerai AE, Colleoni M. Transient early expression of TNF-alpha in sciatic nerve and dorsal root ganglia in a mouse model of painful peripheral neuropathy. Neurosci Lett 2008; 436: 210-213.
53. 53. Onda A, Hamba M, Yabuki S, Kikuchi S. Exogenous tumor necrosis factor-alpha induces abnormal discharges in rat dorsal horn neurons. Spine 2002; 27: 1618-1624. ([discussion 1624]). (Pubitemid 34839643)
54. 54. Cuellar JM, Montesano PX, Carstens E. Role of TNFalpha in sensitization of nociceptive dorsal horn neurons induced by application of nucleus pulposus to L5 dorsal root ganglion in rats. Pain 2004; 110: 578-587. (Pubitemid 39036789)
55. 55. Moss A, Beggs S, Vega-Avelaira D, et al. Spinal microglia and neuropathic pain in young rats. Pain 2007; 128: 215-224. (Pubitemid 46367416)
56. Zimmermann M. Pathobiology of neuropathic pain. Eur J Pharmacol 2001; 429: 23-37.
57. 57. Spengler RN, Sud R, Knight PR, Ignatowski TA. Antinociception mediated by alpha(2)-adrenergic activation involves increasing tumor necrosis factor alpha (TNFalpha) expression and restoring TNFalpha and alpha(2)-adrenergic inhibition of norepinephrine release. Neuropharmacology 2007; 52: 576-589. (Pubitemid 46123374)
58. 58. Hong S, Morrow TJ, Paulson PE, Isom LL, Wiley JW. Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat. J Biol Chem 2004; 279: 29341-29350. (Pubitemid 38915812)
59. Truini A, Galeotti F, Haanpaa M, et al. Pathophysiology of pain in postherpetic neuralgia: a clinical and neurophysiological study. Pain 2008; 140: 405-410.
60. 60. Osterberg A, Boivie J, Thuomas KA. Central pain in multiple sclerosis-prevalence and clinical characteristics. Eur J Pain 2005; 9: 531-542. (Pubitemid 41222322)
61. White FA, Wilson NM. Chemokines as pain mediators and modulators. Curr Opin Anaesthesiol 2008; 21: 580-585.
62. Mika J. Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness. Pharmacol Rep 2008; 60: 297-307.
63. Mata M, Hao S, Fink DJ. Gene therapy directed at the neuroimmune component of chronic pain with particular attention to the role of TNF alpha. Neurosci Lett 2008; 437: 209-213.
64. 64. Sekerkova G, Malatova Z, Zigova T. Neovascularization of the dorsal root ganglia transplanted into the olfactory bulb of neonatal rats. Arch Ital Biol 1996; 134: 291-304. (Pubitemid 26364245)
65. 65. Tsiang H, Lycke E, Ceccaldi PE, Ermine A, Hirardot X. The anterograde transport of rabies virus in rat sensory dorsal root ganglia neurons. J Gen Virol 1989; 70(Pt 8): 2075-2085. (Pubitemid 19215111)
66. Youn DH, Wang H, Jeong SJ. Exogenous tumor necrosis factor-alpha rapidly alters synaptic and sensory transmission in the adult rat spinal cord dorsal horn. J Neurosci Res 2008; 86: 2867-2875.
67. Kawasaki Y, Zhang L, Cheng JK, Ji RR, Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1 beta, interleukin-6, and tumor necrosis factoralpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 2008; 28: 5189-5194.
68. 68. Wei XH, Zang Y, Wu CY, Xu JT, Xin WJ, Liu XG. Perisciatic administration of recombinant rat TNF-alpha induces mechanical allodynia via upregulation of TNFalpha in dorsal root ganglia and in spinal dorsal horn: the role of NF-kappa B pathway. Exp Neurol 2007; 205: 471-484. (Pubitemid 46755768)
69. Ren XT, Wu WP, Xu QG, Huang DH. Change of CCR7 and CD45RA after blocking of Kv 1.3 potassium channel of CD4+ T lymphocytes in multiple sclerosis. Zhonghua Yi Xue Za Zhi 2008; 88: 1896-1899.
70. 70. Bimal S, Singh SK, Sinha S, et al. Leishmania donovani: role of CD2 on CD4+ T-cell function in Visceral Leishmaniasis. Exp Parasitai 2008; 118: 238-246. (Pubitemid 350309305)